MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 142 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 1.87 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,669,421 | -36.9% | 18,300 | 0.0% | 0.90% | -30.1% |
Q2 2023 | $4,227,300 | +1114.7% | 18,300 | +242.1% | 1.29% | +1049.1% |
Q3 2022 | $348,000 | -93.5% | 5,350 | +1296.9% | 0.11% | +100.0% |
Q2 2022 | $5,350,000 | +5.6% | 383 | -92.8% | 0.06% | -95.1% |
Q1 2022 | $5,066,000 | +208.7% | 5,350 | -46.5% | 1.14% | +46.4% |
Q3 2018 | $1,641,000 | -41.2% | 10,000 | 0.0% | 0.78% | -27.2% |
Q2 2018 | $2,790,000 | +21.7% | 10,000 | -60.0% | 1.07% | +32.5% |
Q4 2017 | $2,293,000 | – | 25,000 | – | 0.81% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HealthCor Management, L.P. | 902,601 | $100,342,000 | 3.87% |
L1 Capital Pty Ltd | 113,464 | $12,608,000 | 2.35% |
Avoro Capital Advisors LLC | 1,225,000 | $136,183,000 | 2.34% |
Tao Capital Management LP | 51,396 | $5,714,000 | 1.40% |
ARMISTICE CAPITAL, LLC | 316,000 | $35,130,000 | 1.20% |
ACUTA CAPITAL PARTNERS, LLC | 32,500 | $3,613,000 | 0.98% |
Capital Impact Advisors, LLC | 24,351 | $2,707,000 | 0.66% |
Baker Brothers Advisors | 1,499,213 | $166,668,000 | 0.63% |
Rock Springs Capital Management LP | 256,768 | $28,545,000 | 0.60% |
SHIKIAR ASSET MANAGEMENT INC | 12,000 | $1,334,000 | 0.48% |